471 |
VEXLEV 500 |
LEVETIRACETAM USP 500 mg |
Film coated Tablets |
Alu-Alu Blister |
Monotherapy of focal seizures with or without secondary generalisation
Adjunctive therapy of focal seizures with or without secondary generalisation
Adjunctive therapy of myoclonic seizures and tonic-clonic seizures |
No |
VE PRODUCTS (LAO) CO.,LTD |
4Care Lifescience Pvt. Ltd. |
INDIA |
CERTIFICATE RELEASED |
12 I 5842/24 |
2024-12-30 |
2029-12-29 |
View |
472 |
VEXMET 1000 XR |
Metformin Hydrochloride USP 1000 mg |
Film coated Tablets |
Alu-Alu Blister |
Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
In adults, VEXMET may be used as monotherapy or in
combination with other oral antidiabetic agents or with insulin.
In children from 10 years of age and adolescents, VEXMET may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in
overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure |
Yes |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5843/24 |
2024-12-30 |
2029-12-29 |
View |
473 |
VEXMET 500 |
Metformin Hydrochloride USP 500 mg |
Film coated Tablets |
Alu-Alu Blister |
Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
In adults, VEXMET may be used as monotherapy or in
combination with other oral antidiabetic agents or with insulin.
In children from 10 years of age and adolescents, VEXMET may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in
overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure |
Yes |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5844/24 |
2024-12-30 |
2029-12-29 |
View |
474 |
VEXMET 850 |
Metformin Hydrochloride USP 850 mg |
Film coated Tablets |
Alu-Alu Blister |
Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
In adults, VEXMET may be used as monotherapy or in
combination with other oral antidiabetic agents or with insulin.
In children from 10 years of age and adolescents, VEXMET may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in
overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure |
Yes |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5845/24 |
2024-12-30 |
2029-12-29 |
View |
475 |
VEXTIS 40 |
Telmisartan USP 40 mg |
Tablets |
Alu-Alu Blister |
Treatment of essential hypertention in adults
Cardiovascular prevention
Reduction of cardiovascular morbidity in adults with
Manifest atherothrombotic cardiovascular disease (history of
coronary heart disease ,stroke,or peripheral arterial disease)or
Type 2 diabetes mellitus with documented target organ damage |
No |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5846/24 |
2024-12-30 |
2029-12-29 |
View |
476 |
VEXTIS 80 |
Telmisartan USP 80 mg |
Tablets |
Alu-Alu Blister |
Treatment of essential hypertention in adults
Cardiovascular prevention
Reduction of cardiovascular morbidity in adults with
Manifest atherothrombotic cardiovascular disease (history of
coronary heart disease ,stroke,or peripheral arterial disease)or
Type 2 diabetes mellitus with documented target organ damage |
No |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5847/24 |
2024-12-30 |
2029-12-29 |
View |
477 |
AMOXICILLIN ORAL SUSPENSION |
AMOXICILLIN TRIHYDRATE EQ.TO AMOXICILLIN 125 MG/5 ML |
POWDER FOR ORAL SUSPENSION |
BOTTLE |
EAR AND THROAT INFECTION, GENITOURINARY TRACT INFECTION, SKIN AND SOFT TISSUE INFECTION, ACUTE UNCOMPLICATED ANOGENITAL AND URETHRAL GONORRHEA |
Yes |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
NORTH CHINA PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
12 I 5831/24 |
2024-12-16 |
2029-12-15 |
View |
478 |
AMOXICILLIN ORAL SUSPENSION |
AMOXICILLIN TRIHYDRATE EQ.TO AMOXICILLIN 250 MG/5 ML |
POWDER FOR ORAL SUSPENSION |
BOTTLE |
EAR AND THROAT INFECTION, GENITOURINARY TRACT INFECTION, SKIN AND SOFT TISSUE INFECTION, ACUTE UNCOMPLICATED ANOGENITAL AND URETHRAL GONORRHEA |
Yes |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
NORTH CHINA PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
12 I 5832/24 |
2024-12-16 |
2029-12-15 |
View |
479 |
CRYSTORVAS TABLET 20 MG |
ATORVASTATIN CALCIUM TRIHYDRATE( CRYSTALLINE) 22.20 MG EQ.TO ATORVASTATIN 20 MG |
FILM COATED TABLET |
ALU-ALU PVC BLISTER |
AS AN ADJUNCT TO DIET FOR THE TREATMENT OF PATIENTS WITH ELEVATED TOTAL CHOLESTEROL, LDL-CHOLESTEROL, APOLIPOPROTEIN B AND TRIGLYCERIDES AND TO INCREASE HDL-CHOLESTEROL IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, COMBINED HYPERLIPIDEMIA (FREDRICKSON TYPES IIA AND IIB), ELEVATED SERUM TRIGLYCERIDE LEVELS (FREDRICKSON TYPE IV) AND FOR PATIENTS WITH DYSBETALIPOPROTEINEMIA (FREDRICKSON TYPE III) WHO DO NOT RESPOND ADEQUATELY TO DIET |
Yes |
DKSH LAOS COMPANY LIMITED |
DUOPHARMA MANUFACTURING(BANGI)SDN.BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 5513/23 |
2023-05-15 |
2026-05-14 |
View |
480 |
CRYSTORVAS TABLET 40 MG |
ATORVASTATIN CALCIUM TRIHYDRATE( CRYSTALLINE) 44.40 MG EQ.TO ATORVASTATIN 40 MG |
FILM COATED TABLET |
ALU-ALU PVC BLISTER |
AS AN ADJUNCT TO DIET FOR THE TREATMENT OF PATIENTS WITH ELEVATED TOTAL CHOLESTEROL, LDL-CHOLESTEROL, APOLIPOPROTEIN B AND TRIGLYCERIDES AND TO INCREASE HDL-CHOLESTEROL IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, COMBINED HYPERLIPIDEMIA (FREDRICKSON TYPES IIA AND IIB), ELEVATED SERUM TRIGLYCERIDE LEVELS (FREDRICKSON TYPE IV) AND FOR PATIENTS WITH DYSBETALIPOPROTEINEMIA (FREDRICKSON TYPE III) WHO DO NOT RESPOND ADEQUATELY TO DIET |
Yes |
DKSH LAOS COMPANY LIMITED |
DUOPHARMA MANUFACTURING(BANGI)SDN.BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 5514/23 |
2023-05-15 |
2026-05-14 |
View |